DNALite Therapeutics is an early-stage preclinical biotechnology company.
DNALite Therapeutics's investors include National Science Foundation, University of California Berkeley, SOSV, SOSV SF & NY (Fka IndieBio), Berkeley Catalyst Fund (BCF).
DNALite Therapeutics is headquartered in San Francisco, United States.
DNALite Therapeutics is an early-stage preclinical biotechnology company.
DNALite Therapeutics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DNALite Therapeutics — Funding & Investors." VCBacked, March 7, 2023, https://www.vcbacked.co/company/dnalite-therapeutics. Accessed November 12, 2026.
VCBacked. (2023). DNALite Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/dnalite-therapeutics
{{cite web |title=DNALite Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dnalite-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at DNALite Therapeutics? Request a listing update